Additionally, our findings showed that NRF2 overexpression promoted tumor growth and increased tumor volume, tumor weight, and Ki-67 expression levels, while treatment with RSL3 reversed these effects (Fig. S3E–H). The gene discussed is MKI67; the disease is neoplasm.